Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksParagon Group Regulatory News (PAG)

Share Price Information for Paragon Group (PAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 732.00
Bid: 732.00
Ask: 734.00
Change: -7.50 (-1.01%)
Spread: 2.00 (0.273%)
Open: 731.50
High: 737.00
Low: 729.50
Prev. Close: 739.50
PAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Supplement

15 Jul 2016 12:13

RNS Number : 3407E
Paragon Group Of Companies PLC
15 July 2016
 

 

The Paragon Group of Companies PLC

Publication of Supplement

15 July 2016

 

The following supplement (the "Supplement") has been approved by the UK Listing Authority and is available for viewing:

Supplement dated 15 July 2016 to the Base Prospectus dated 22 January 2016 relating to The Paragon Group of Companies PLC £1,000,000,000 Euro Medium Term Note Programme.

Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.

To view the Supplement, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/3407E_-2016-7-15.pdfA copy of the Supplement will also be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.

For further information, please contact:

Investor Relations

The Paragon Group of Companies PLC

Address: 51 Homer Road

Solihull

West Midlands

B91 3QJ

 

Telephone: 0845 849 4003

Fax: 0207 786 8484

 

Email: investor.relations@paragon-group.co.uk

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement is not for distribution in the United States.

Please note that the information contained in the Base Prospectus as supplemented by the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus as supplemented by the Supplement) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus as supplemented by the Supplement is not addressed. Prior to relying on the information contained in the Base Prospectus as supplemented by the Supplement you must ascertain from the Base Prospectus as supplemented by the Supplement whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.

In particular, neither this announcement nor the Base Prospectus as supplemented by the Supplement shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Base Prospectus as supplemented by the Supplement have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"). Subject to certain exceptions, the securities may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons. The securities are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPSFMFFIFMSESW
Date   Source Headline
27th Aug 20195:07 pmRNSTransaction in Own Shares
23rd Aug 20194:42 pmRNSTransaction in Own Shares
22nd Aug 20195:17 pmRNSTransaction in Own Shares
21st Aug 20195:24 pmRNSTransaction in Own Shares
20th Aug 20195:05 pmRNSTransaction in Own Shares
19th Aug 20195:25 pmRNSTransaction in Own Shares
16th Aug 20194:58 pmRNSTransaction in Own Shares
15th Aug 20195:03 pmRNSTransaction in Own Shares
14th Aug 20195:33 pmRNSTransaction in Own Shares
13th Aug 20195:07 pmRNSTransaction in Own Shares
12th Aug 20195:11 pmRNSTransaction in Own Shares
9th Aug 20194:57 pmRNSTransaction in Own Shares
9th Aug 20191:41 pmRNSHolding(s) in Company
8th Aug 20195:15 pmRNSTransaction in Own Shares
7th Aug 20195:15 pmRNSTransaction in Own Shares
6th Aug 20195:08 pmRNSTransaction in Own Shares
5th Aug 20195:21 pmRNSTransaction in Own Shares
5th Aug 20194:49 pmRNSDirector/PDMR Shareholding
2nd Aug 20194:51 pmRNSTransaction in Own Shares
1st Aug 20194:58 pmRNSTransaction in Own Shares
1st Aug 20194:02 pmRNSTotal Voting Rights
31st Jul 20195:16 pmRNSTransaction in Own Shares
31st Jul 20194:34 pmRNSCancellation of Treasury Shares
30th Jul 20195:01 pmRNSTransaction in Own Shares
29th Jul 20195:01 pmRNSTransaction in Own Shares
26th Jul 20194:40 pmRNSTransaction in Own Shares
25th Jul 20195:29 pmRNSTransaction in Own Shares
24th Jul 20195:08 pmRNSTransaction in Own Shares
23rd Jul 20195:03 pmRNSTransaction in Own Shares
23rd Jul 20194:08 pmRNSDirector/PDMR Shareholding
23rd Jul 20197:00 amRNSTrading Update
22nd Jul 20195:06 pmRNSTransaction in Own Shares
19th Jul 20195:07 pmRNSTransaction in Own Shares
19th Jul 20193:57 pmRNSAdditional Listing
18th Jul 20195:37 pmRNSTransaction in Own Shares
17th Jul 20195:16 pmRNSTransaction in Own Shares
16th Jul 20195:03 pmRNSTransaction in Own Shares
15th Jul 20195:35 pmRNSTransaction in Own Shares
12th Jul 20194:45 pmRNSTransaction in Own Shares
11th Jul 20195:00 pmRNSTransaction in Own Shares
3rd Jul 201911:17 amRNSCompletion of securitisation
1st Jul 20192:45 pmRNSDirector/PDMR Shareholding
1st Jul 201912:06 pmRNSTotal Voting Rights
28th Jun 20193:25 pmRNSDirector/PDMR Shareholding
27th Jun 20194:44 pmRNSListing Rule 9.6.14(R) Disclosure
3rd Jun 201910:33 amRNSBlock listing Interim Review
31st May 20195:00 pmRNSTotal Voting Rights
22nd May 20197:00 amRNSHalf-year Report
30th Apr 20195:00 pmRNSTotal Voting Rights
10th Apr 20199:47 amRNSListing Rule 9.6.14(R) Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.